Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (6)

Search Parameters:
Keywords = Remote Ischaemic Preconditioning

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 3729 KiB  
Article
NGAL in the Development of Acute Kidney Injury in a Murine Model of Remote Ischaemic Preconditioning and Liver Ischaemia Reperfusion
by Esther Platt, Francis Robertson, Ali Al-Rashed, Riko Klootwijk, Andrew Hall, Alberto Quaglia, Alan Salama, Lauren Heptinstall and Brian Davidson
Int. J. Mol. Sci. 2024, 25(10), 5061; https://doi.org/10.3390/ijms25105061 - 7 May 2024
Cited by 1 | Viewed by 994
Abstract
Acute kidney injury (AKI) is common following liver transplantation and is associated with liver ischeamia reperfusion (IR) injury. The purpose of this study was to use a mouse model of liver IR injury and AKI to study the role of Neutrophil Gelatinase Associated [...] Read more.
Acute kidney injury (AKI) is common following liver transplantation and is associated with liver ischeamia reperfusion (IR) injury. The purpose of this study was to use a mouse model of liver IR injury and AKI to study the role of Neutrophil Gelatinase Associated Lipocalin (NGAL), a biomarker of AKI, in liver IR injury and AKI. We demonstrate an adapted, reproducible model of liver IR injury and AKI in which remote ischemic preconditioning (RIPC) by repeated episodes of hindleg ischemia prior to liver IR reduced the severity of the IR injury. In this model, serum NGAL at 2 h post reperfusion correlated with AKI development early following IR injury. This early rise in serum NGAL was associated with hepatic but not renal upregulation of NGAL mRNA, suggesting NGAL production in the liver but not the kidney in the early phase post liver IR injury. Full article
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>–<b>d</b>) Biochemical markers of liver and renal injury at 2 h post liver reperfusion. Plasma transaminases (AST and ALT) measured at two hours post liver reperfusion were used as surrogate markers of liver injury and confirmed injury in the liver Ischaemia Reperfusion (IR) group (<b>a</b>,<b>b</b>). Liver IR was provided by a single episode of 45 min of clamping the left and middle portal pedicles followed by 120 min of reperfusion. Liver injury was attenuated by pre-treatment with Remote Ischaemic Pre-Conditioning (RIPC) in the form of intermittent clamping of the femoral vessels for 5 min episodes with reperfusion in between and was not seen in either the sham laparotomy or RIPC only groups. Liver IR injury was accompanied by renal injury, demonstrated by a statistically significant increase in plasma creatinine compared to the sham laparotomy ((<b>c</b>), <span class="html-italic">p</span> = 0.0007). Renal injury was attenuated by pre-treatment with RIPC. Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) concentration at two hours post reperfusion was significantly elevated in the Liver IR group but was reduced to control levels with RIPC pre-treatment (<b>d</b>). Dotted lines denote the normal values for plasma AST, ALT, and creatinine in mice. (<b>e</b>) Histological evidence of liver injury. Histological specimens confirmed oxidative injury with increased staining for DNA/RNA oxidative damage in renal specimens from the liver IR group compared to the sham; injury was attenuated by RIPC (<b>e</b>). <span class="html-italic">N</span> = 12 mice/experimental group for biochemical measurements.</p>
Full article ">Figure 1 Cont.
<p>(<b>a</b>–<b>d</b>) Biochemical markers of liver and renal injury at 2 h post liver reperfusion. Plasma transaminases (AST and ALT) measured at two hours post liver reperfusion were used as surrogate markers of liver injury and confirmed injury in the liver Ischaemia Reperfusion (IR) group (<b>a</b>,<b>b</b>). Liver IR was provided by a single episode of 45 min of clamping the left and middle portal pedicles followed by 120 min of reperfusion. Liver injury was attenuated by pre-treatment with Remote Ischaemic Pre-Conditioning (RIPC) in the form of intermittent clamping of the femoral vessels for 5 min episodes with reperfusion in between and was not seen in either the sham laparotomy or RIPC only groups. Liver IR injury was accompanied by renal injury, demonstrated by a statistically significant increase in plasma creatinine compared to the sham laparotomy ((<b>c</b>), <span class="html-italic">p</span> = 0.0007). Renal injury was attenuated by pre-treatment with RIPC. Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) concentration at two hours post reperfusion was significantly elevated in the Liver IR group but was reduced to control levels with RIPC pre-treatment (<b>d</b>). Dotted lines denote the normal values for plasma AST, ALT, and creatinine in mice. (<b>e</b>) Histological evidence of liver injury. Histological specimens confirmed oxidative injury with increased staining for DNA/RNA oxidative damage in renal specimens from the liver IR group compared to the sham; injury was attenuated by RIPC (<b>e</b>). <span class="html-italic">N</span> = 12 mice/experimental group for biochemical measurements.</p>
Full article ">Figure 2
<p>Fold change in NGAL mRNA in each of the experimental groups compared to sham laparotomy for (<b>a</b>) liver and (<b>b</b>) kidney specimens. Median values and interquartile ranges are shown. Statistical analysis was performed using Kruskal–Wallis and Mann–Whitney tests as appropriate. “Ischaemic” and “non-ischaemic” denotes which liver lobe from the animal was sampled. With regards to statistical significance of result compared to sham laparotomy, “ns” denotes not significant (<span class="html-italic">p</span> ≥ 0.05), * denotes <span class="html-italic">p</span> ≤ 0.05, and ** denotes <span class="html-italic">p</span> ≤ 0.01. Statistically significant <span class="html-italic">p</span> values are provided in the text. <span class="html-italic">N</span> = 6 mice/experimental group.</p>
Full article ">Figure 3
<p>Neutrophil Gelatinase Associated Lipocalin (NGAL) staining on background of haemoxylin/eosin. Cells stained for NGAL are brown, as shown in (<b>a</b>–<b>c</b>). (<b>a</b>) is from a ‘sham’ liver section, (<b>b</b>) is from ‘liver Ischaemia Reperfusion (IR)—ischaemic lobe’ and (<b>c</b>) is from ‘liver IR—non-ischaemic lobe’. All samples demonstrated NGAL staining with no difference between the groups. Hepatocytes did not stain positively for NGAL and so further staining was performed to identify the NGAL positive cells using F4/80, a marker of macrophages. (<b>d</b>) demonstrates co-localization of NGAL (pink) and F4/80 (brown) in a ‘liver IR’ liver section, with co-localization shown by yellow overlay in (<b>e</b>). (<b>f</b>) NGAL staining within the kidney from the “liver IR” group, with NGAL (brown) positively staining within the apical third of tubular cells. Histological evidence of either liver or renal injury was not demonstrated with H&amp;E staining, and inflammatory cells were not observed. 40× magnification for all images. <span class="html-italic">N</span> = 6 mice/experimental group.</p>
Full article ">Figure 4
<p>Diagram to show experimental protocol. Mice were randomly assigned to one of four groups. Overall duration of anaesthesia prior to termination was identical across the groups at 240 min.</p>
Full article ">Figure A1
<p>Liver H&amp;E staining from (<b>a</b>) sham laparotomy, (<b>b</b>) liver Ischaemia Reperfusion (IR)—ischemic lobe and (<b>c</b>) liver IR—non ischemic lobe. Kidney H&amp;E staining from (<b>d</b>) sham laparotomy and (<b>e</b>) liver IR. Histological evidence of injury was not demonstrated in either liver or kidney specimens. All images at 40× magnification.</p>
Full article ">Figure A2
<p>(<b>a</b>) Number of Neutrophil Gelatinase Associated Lipocalin (NGAL) staining cells/10 high-powered fields from A: sham laparotomy, B1: liver Ischaemia Reperfusion (IR)—ischemic lobe, B2: liver IR—non ischaemic lobe, C: Remote Ischaemic Pre-Conditioning (RIPC), D1: RIPC + liver IR—ischaemic lobe, and D2: RIPC + liver IR—non ischaemic lobe with no difference between the groups (<span class="html-italic">p</span> ≥ 0.05). (<b>b</b>) Proportion of tubules stained for NGAL in kidney specimens, with no difference between the groups.</p>
Full article ">
14 pages, 1337 KiB  
Article
Effect of Remote Ischaemic Preconditioning on Perioperative Endothelial Dysfunction in Non-Cardiac Surgery: A Randomised Clinical Trial
by Kirsten L. Wahlstrøm, Hannah F. Hansen, Madeline Kvist, Jakob Burcharth, Jens Lykkesfeldt, Ismail Gögenur and Sarah Ekeloef
Cells 2023, 12(6), 911; https://doi.org/10.3390/cells12060911 - 16 Mar 2023
Cited by 3 | Viewed by 2002
Abstract
Endothelial dysfunction result from inflammation and excessive production of reactive oxygen species as part of the surgical stress response. Remote ischemic preconditioning (RIPC) potentially exerts anti-oxidative and anti-inflammatory properties, which might stabilise the endothelial function after non-cardiac surgery. This was a single centre [...] Read more.
Endothelial dysfunction result from inflammation and excessive production of reactive oxygen species as part of the surgical stress response. Remote ischemic preconditioning (RIPC) potentially exerts anti-oxidative and anti-inflammatory properties, which might stabilise the endothelial function after non-cardiac surgery. This was a single centre randomised clinical trial including 60 patients undergoing sub-acute laparoscopic cholecystectomy due to acute cholecystitis. Patients were randomised to RIPC or control. The RIPC procedure consisted of four cycles of five minutes of ischaemia and reperfusion of one upper extremity. Endothelial function was assessed as the reactive hyperaemia index (RHI) and circulating biomarkers of nitric oxide (NO) bioavailability (L-arginine, asymmetric dimethylarginine (ADMA), L-arginine/ADMA ratio, tetra- and dihydrobiopterin (BH4 and BH2), and total plasma biopterin) preoperative, 2–4 h after surgery and 24 h after surgery. RHI did not differ between the groups (p = 0.07). Neither did levels of circulating biomarkers of NO bioavailability change in response to RIPC. L-arginine and L-arginine/ADMA ratio was suppressed preoperatively and increased 24 h after surgery (p < 0.001). The BH4/BH2-ratio had a high preoperative level, decreased 2–4 h after surgery and remained low 24 h after surgery (p = 0.01). RIPC did not influence endothelial function or markers of NO bioavailability until 24 h after sub-acute laparoscopic cholecystectomy. In response to surgery, markers of NO bioavailability increased, and oxidative stress decreased. These findings support that a minimally invasive removal of the inflamed gallbladder countereffects reduced markers of NO bioavailability and increased oxidative stress caused by acute cholecystitis. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Patient selection flow chart.</p>
Full article ">Figure 2
<p>Endothelial function and markers of NO bioavailability stratified by remote ischemic preconditioning in patients undergoing surgery. Means and 95% CI of reactive hyperaemia index (RHI), L-arginine, asymmetric dimethylarginine (ADMA), L-arginine/ADMA-ratio, tetrahydrobiopterin (BH<sub>4</sub>), dihydrobiopterin (BH<sub>2</sub>), BH<sub>4</sub>/BH<sub>2</sub>-ratio, and total biopterin concentration in relation to surgery in patients undergoing remote ischemic preconditioning (RIPC) and controls. Preop = preoperative; 2–4 h = two–four hours after surgery; POD1 = 24 h after surgery. <span class="html-italic">p</span>-values are given for the overall difference between groups. Created with R studio and <a href="http://www.BioRender.com" target="_blank">www.BioRender.com</a> (accessed on 20 February 2023).</p>
Full article ">Figure 3
<p>Changes of endothelial function and markers of NO bioavailability in patients undergoing surgery. Boxplots illustrating changes of reactive hyperaemia index (RHI) and plasma concentrations of L-arginine, asymmetric dimethylarginine (ADMA), L-arginine/ADMA-ratio, tetrahydrobiopterin (BH<sub>4</sub>), dihydrobiopterin (BH<sub>2</sub>), BH<sub>4</sub>/BH<sub>2</sub>-ratio, and total biopterin in relation to surgery. Box plots show median with variance with lower and upper hinges representing the 25th and 75th percentile, respectively. White circles represent measurements below or above the 25th and 75th percentile. Preop = preoperative; 2–4 h = two–four hours after surgery; POD1 = 24 h after surgery. <span class="html-italic">p</span>-values are given for the overall changes in time. *** <span class="html-italic">p</span> &lt; 0.001 ** <span class="html-italic">p</span> &lt; 0.05. Created with R studio and <a href="http://www.BioRender.com" target="_blank">www.BioRender.com</a> (accessed on 20 February 2023).</p>
Full article ">
12 pages, 1656 KiB  
Article
Remote Ischaemic Preconditioning in Intra-Abdominal Cancer Surgery (RIPCa): A Pilot Randomised Controlled Trial
by Aikaterini Papadopoulou, Matthew Dickinson, Theophilus L. Samuels, Christian Heiss, Julie Hunt, Lui Forni and Ben C. Creagh-Brown
J. Clin. Med. 2022, 11(7), 1770; https://doi.org/10.3390/jcm11071770 - 23 Mar 2022
Cited by 1 | Viewed by 2156
Abstract
There is limited evidence on the effect of remote ischaemic preconditioning (RIPC) following non-cardiac surgery. The aim of this study was to investigate the effect of RIPC on morbidity following intra-abdominal cancer surgery. We conducted a double blinded pilot randomised controlled trial that [...] Read more.
There is limited evidence on the effect of remote ischaemic preconditioning (RIPC) following non-cardiac surgery. The aim of this study was to investigate the effect of RIPC on morbidity following intra-abdominal cancer surgery. We conducted a double blinded pilot randomised controlled trial that included 47 patients undergoing surgery for gynaecological, pancreatic and colorectal malignancies. The patients were randomized into an intervention (RIPC) or control group. RIPC was provided by intermittent inflations of an upper limb tourniquet. The primary outcome was feasibility of the study, and the main secondary outcome was postoperative morbidity including perioperative troponin change and the urinary biomarkers tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein 7 (TIMP-2*IGFBP-7). The recruitment target was reached, and the protocol procedures were followed. The intervention group developed fewer surgical complications at 30 days (4.5% vs. 33%), 90 days (9.5% vs. 35%) and 6 months (11% vs. 41%) (adjusted p 0.033, 0.044 and 0.044, respectively). RIPC was a significant independent variable for lower overall postoperative morbidity survey (POMS) score, OR 0.79 (95% CI 0.63 to 0.99) and fewer complications at 6 months including pulmonary OR 0.2 (95% CI 0.03 to 0.92), surgical OR 0.12 (95% CI 0.007 to 0.89) and overall complications, OR 0.18 (95% CI 0.03 to 0.74). There was no difference in perioperative troponin change or TIMP2*IGFBP-7. Our pilot study suggests that RIPC may improve outcomes following intra-abdominal cancer surgery and that a larger trial would be feasible. Full article
(This article belongs to the Section General Surgery)
Show Figures

Figure 1

Figure 1
<p>Consort diagram.</p>
Full article ">Figure 2
<p>Boxplot of Postoperative Morbidity Survey (POMS) score on day 2 (4 [1, 5] vs. 5 [3, 6], adjusted <span class="html-italic">p</span> = 0.185), day 3 (2 [0.75, 4] vs. 4 [1.5, 5], adjusted <span class="html-italic">p</span> = 0.226) and day 5 (0 [0, 1.25] vs. 2 [0, 3], adjusted <span class="html-italic">p</span> = 0.159), in the intervention (RIPC) and control groups.</p>
Full article ">Figure 3
<p>Barplot of postoperative complications (American College of Surgeons) at day 30 (11/23 (47.82%) vs. 15/22 (68.18%)), day 90 (12/23 (52.17%) vs. 17/21 (80.95%)) and day 180 (12/22 (54.55% vs. 17/20 (85%)), <span class="html-italic">p</span> = 0.003 in the intervention (RIPC) and control groups, respectively. <span class="html-graphic" id="jcm-11-01770-i001"><img alt="Jcm 11 01770 i001" src="/jcm/jcm-11-01770/article_deploy/html/images/jcm-11-01770-i001.png"/></span> RIPC group without morbidity, <span class="html-graphic" id="jcm-11-01770-i002"><img alt="Jcm 11 01770 i002" src="/jcm/jcm-11-01770/article_deploy/html/images/jcm-11-01770-i002.png"/></span> RIPC group with morbidity, <span class="html-graphic" id="jcm-11-01770-i003"><img alt="Jcm 11 01770 i003" src="/jcm/jcm-11-01770/article_deploy/html/images/jcm-11-01770-i003.png"/></span> Control group without morbidity, <span class="html-graphic" id="jcm-11-01770-i004"><img alt="Jcm 11 01770 i004" src="/jcm/jcm-11-01770/article_deploy/html/images/jcm-11-01770-i004.png"/></span> Control group with morbidity.</p>
Full article ">
13 pages, 4506 KiB  
Article
Effects of Remote Ischaemic Preconditioning on the Internal Thoracic Artery Nitric Oxide Synthase Isoforms in Patients Undergoing Coronary Artery Bypass Grafting
by Aleksandra Jankovic, Tamara Zakic, Miroslav Milicic, Dragana Unic-Stojanovic, Andjelika Kalezic, Aleksandra Korac, Miomir Jovic and Bato Korac
Antioxidants 2021, 10(12), 1910; https://doi.org/10.3390/antiox10121910 - 29 Nov 2021
Cited by 2 | Viewed by 2055
Abstract
Remote ischaemic preconditioning (RIPC) is a medical procedure that consists of repeated brief periods of transient ischaemia and reperfusion of distant organs (limbs) with the ability to provide internal organ protection from ischaemia. Even though RIPC has been successfully applied in patients with [...] Read more.
Remote ischaemic preconditioning (RIPC) is a medical procedure that consists of repeated brief periods of transient ischaemia and reperfusion of distant organs (limbs) with the ability to provide internal organ protection from ischaemia. Even though RIPC has been successfully applied in patients with myocardial infarction during coronary revascularization (surgery/percutaneous angioplasty), the underlying molecular mechanisms are yet to be clarified. Thus, our study aimed to determine the role of nitric oxide synthase (NOS) isoforms in RIPC-induced protection (3 × 5 min of forearm ischaemia with 5 min of reperfusion) of arterial graft in patients undergoing urgent coronary artery bypass grafting (CABG). We examined RIPC effects on specific expression and immunolocalization of three NOS isoforms — endothelial (eNOS), inducible (iNOS) and neuronal (nNOS) in patients’ internal thoracic artery (ITA) used as a graft. We found that the application of RIPC protocol leads to an increased protein expression of eNOS, which was further confirmed with strong eNOS immunopositivity, especially in the endothelium and smooth muscle cells of ITA. The same analysis of two other NOS isoforms, iNOS and nNOS, showed no significant differences between patients undergoing CABG with or without RIPC. Our results demonstrate RIPC-induced upregulation of eNOS in human ITA, pointing to its significance in achieving protective phenotype on a systemic level with important implications for graft patency. Full article
(This article belongs to the Special Issue NOS/NO System and Heart)
Show Figures

Figure 1

Figure 1
<p>Western blot data showing protein expression of eNOS, iNOS, and nNOS in ITA of non-RIPC (control) patients (left) and patients with applied RIPC protocol (right) during urgent CABG (<b>A</b>). Representative bands from the same blot corresponding to seven patients in each group are shown. Data obtained after quantification of specific bands expressed as % of the control group taken as 100% (<b>B</b>). Bars represent the mean ± S.E.M. *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>Immunohistochemical analysis of eNOS in tunica interna (ti), tunica media (tm) and tunica adventitia (ta) of ITA from non-RIPC (control) patients (<b>left</b>) and patients with applied RIPC protocol (<b>right</b>) during urgent CABG. Immunopositivity for eNOS in non-RIPC patients is mostly visible in the endothelium, while RIPC patients demonstrate high eNOS immunopositivity in all three layers of ITA. Scale bar: 50 µm.</p>
Full article ">Figure 3
<p>Immunohistochemical analysis of iNOS in tunica interna (ti) and tunica media (tm) of ITA from non-RIPC (control) patients (<b>left</b>) and patients with applied RIPC protocol (<b>right</b>) during urgent CABG. Immunopositivity for iNOS in non-RIPC patients is weak, mostly detected in the endothelium, while RIPC patients show slightly higher iNOS immunopositivity in tunica interna and tunica media in smooth muscle cells. Scale bar: 50 µm.</p>
Full article ">Figure 4
<p>Immunohistochemical analysis of nNOS in tunica interna (ti) and tunica media (tm) of ITA from non-RIPC (control) patients (<b>left</b>) and patients with applied RIPC protocol (<b>right</b>) during urgent CABG. Immunopositivity for nNOS in both non-RIPC patients and RIPC patients was primarily detected in smooth muscle cells, while weak endothelial nNOS immunopositivity was observed in some cases. Insert: nNOS expressing cells. Scale bar: 50 µm.</p>
Full article ">Figure 5
<p>Light (LM) and electron microscopy (EM) of ITA from non-RIPC (control) patients (<b>left</b>) and patients with applied RIPC protocol (<b>right</b>) during urgent CABG. Semithin sections stained with toluidine blue and corresponding ultrathin sections. Magnified smooth muscle cells showed different phenotypes, contractile in non-RIPC (control) patients (<b>left</b>) and relaxed in patients with applied RIPC protocol (<b>right</b>). eNOS (IHC eNOS) was found to be highly expressed in relaxed smooth muscle cells. ti-tunica interna; tm-tunica media; sm-smooth muscle cell; arrow-lamina elastica interna; n-nucleus; open arrowhead-dense body and dense plaque; white arrowhead-perinuclear located synthetic organelles. Scale bar: LM-10 µm, EM-5 µm, IHC eNOS-20 µm.</p>
Full article ">
29 pages, 1783 KiB  
Review
Effects of Cardiovascular Risk Factors on Cardiac STAT3
by Márton Pipicz, Virág Demján, Márta Sárközy and Tamás Csont
Int. J. Mol. Sci. 2018, 19(11), 3572; https://doi.org/10.3390/ijms19113572 - 12 Nov 2018
Cited by 40 | Viewed by 6449
Abstract
Nuclear, mitochondrial and cytoplasmic signal transducer and activator of transcription 3 (STAT3) regulates many cellular processes, e.g., the transcription or opening of mitochondrial permeability transition pore, and its activity depends on the phosphorylation of Tyr705 and/or Ser727 sites. In the heterogeneous network of [...] Read more.
Nuclear, mitochondrial and cytoplasmic signal transducer and activator of transcription 3 (STAT3) regulates many cellular processes, e.g., the transcription or opening of mitochondrial permeability transition pore, and its activity depends on the phosphorylation of Tyr705 and/or Ser727 sites. In the heterogeneous network of cardiac cells, STAT3 promotes cardiac muscle differentiation, vascular element formation and extracellular matrix homeostasis. Overwhelming evidence suggests that STAT3 is beneficial for the heart, plays a role in the prevention of age-related and postpartum heart failure, protects the heart against cardiotoxic doxorubicin or ischaemia/reperfusion injury, and is involved in many cardioprotective strategies (e.g., ischaemic preconditioning, perconditioning, postconditioning, remote or pharmacological conditioning). Ischaemic heart disease is still the leading cause of death worldwide, and many cardiovascular risk factors contribute to the development of the disease. This review focuses on the effects of various cardiovascular risk factors (diabetes, aging, obesity, smoking, alcohol, depression, gender, comedications) on cardiac STAT3 under non-ischaemic baseline conditions, and in settings of ischaemia/reperfusion injury with or without cardioprotective strategies. Full article
(This article belongs to the Special Issue Advances in Biological Functions of STAT3)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>STAT3 signalling in cardiac myocytes in settings of ischaemia/reperfusion. ETC: electron transport chain; GP: glycoprotein; JAK: Janus kinase; mPTP: mitochondrial permeability transition pore; MnSOD: manganese-dependent superoxide dismutase; VEGF: vascular endothelial growth factor. (P in circle represents phosphorylated STAT3 forms; dashed arrow indicates several steps; plus (+) sign represents activation).</p>
Full article ">Figure 2
<p>Cardiovascular risk factors and cardiac STAT3 activation under non-ischaemic baseline conditions. (P in circle represents phosphorylated STAT3 form; dotted arrow and question mark indicate inconclusive effects of risk factors).</p>
Full article ">Figure 3
<p>Summary of the effects of various cardiovascular risk factors on cardiac STAT3 activation due to ischaemia/reperfusion and ischaemic or pharmacological conditionings. (P in circle represents phosphorylated STAT3 form. Dotted lines indicate solely proposed effects due to insufficient number of studies. Plus (+) and minus (−) signs represent activation and inhibition, respectively).</p>
Full article ">
823 KiB  
Review
An Evaluation of Ischaemic Preconditioning as a Method of Reducing Ischaemia Reperfusion Injury in Liver Surgery and Transplantation
by Francis P. Robertson, Barry J. Fuller and Brian R. Davidson
J. Clin. Med. 2017, 6(7), 69; https://doi.org/10.3390/jcm6070069 - 14 Jul 2017
Cited by 40 | Viewed by 7489
Abstract
Liver Ischaemia Reperfusion (IR) injury is a major cause of post-operative liver dysfunction, morbidity and mortality following liver resection surgery and transplantation. There are no proven therapies for IR injury in clinical practice and new approaches are required. Ischaemic Preconditioning (IPC) can be [...] Read more.
Liver Ischaemia Reperfusion (IR) injury is a major cause of post-operative liver dysfunction, morbidity and mortality following liver resection surgery and transplantation. There are no proven therapies for IR injury in clinical practice and new approaches are required. Ischaemic Preconditioning (IPC) can be applied in both a direct and remote fashion and has been shown to ameliorate IR injury in small animal models. Its translation into clinical practice has been difficult, primarily by a lack of knowledge regarding the dominant protective mechanisms that it employs. A review of all current studies would suggest that IPC/RIPC relies on creating a small tissue injury resulting in the release of adenosine and l-arginine which act through the Adenosine receptors and the haem-oxygenase and endothelial nitric oxide synthase systems to reduce hepatocyte necrosis and improve the hepatic microcirculation post reperfusion. The next key step is to determine how long the stimulus requires to precondition humans to allow sufficient injury to occur to release the potential mediators. This would open the door to a new therapeutic chapter in this field. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Previously identified mechanism of IPC. Mechanisms identified in the setting of liver IR injury are in black whilst those not implicated/researched are in white.</p>
Full article ">Figure 2
<p>Protective mechanisms of adenosine release following Ischaemic Preconditioning (IPC).</p>
Full article ">
Back to TopTop